Financials AS Latvijas Juras medicinas centrs
Equities
UOM
LV0000100741
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.85 EUR | -1.67% | -1.67% | -16.51% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 3.984 | 3.968 | 5.96 | 10.16 | 9.52 | 8.48 |
Enterprise Value (EV) 1 | 2.14 | 1.981 | 4.195 | 9.143 | 8.199 | 7.805 |
P/E ratio | -49.9 x | 23.7 x | 21.8 x | 11.5 x | 15.2 x | -13.6 x |
Yield | 2.01% | - | 0.94% | 1.57% | - | - |
Capitalization / Revenue | 0.6 x | 0.55 x | 0.84 x | 1.09 x | 0.98 x | 0.86 x |
EV / Revenue | 0.32 x | 0.27 x | 0.59 x | 0.98 x | 0.85 x | 0.79 x |
EV / EBITDA | 17.6 x | 5.71 x | 8.23 x | 7.83 x | 7.78 x | 16.3 x |
EV / FCF | 12.3 x | 9.7 x | 24.5 x | -9.32 x | 28.7 x | -7.77 x |
FCF Yield | 8.14% | 10.3% | 4.08% | -10.7% | 3.48% | -12.9% |
Price to Book | 0.74 x | 0.72 x | 1.08 x | 1.6 x | 1.4 x | 1.37 x |
Nbr of stocks (in thousands) | 800 | 800 | 800 | 800 | 800 | 800 |
Reference price 2 | 4.980 | 4.960 | 7.450 | 12.70 | 11.90 | 10.60 |
Announcement Date | 29/04/19 | 21/02/20 | 21/04/21 | 28/04/22 | 30/04/24 | 30/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 6.674 | 7.27 | 7.081 | 9.364 | 9.701 | 9.851 |
EBITDA 1 | 0.1216 | 0.3468 | 0.5094 | 1.168 | 1.054 | 0.4787 |
EBIT 1 | -0.0791 | 0.1499 | 0.2746 | 0.8809 | 0.6263 | -0.0726 |
Operating Margin | -1.18% | 2.06% | 3.88% | 9.41% | 6.46% | -0.74% |
Earnings before Tax (EBT) 1 | -0.0793 | 0.1678 | 0.2746 | 0.8809 | 0.6263 | -0.6234 |
Net income 1 | -0.0798 | 0.1678 | 0.2736 | 0.8803 | 0.6257 | -0.6242 |
Net margin | -1.2% | 2.31% | 3.86% | 9.4% | 6.45% | -6.34% |
EPS 2 | -0.0998 | 0.2097 | 0.3419 | 1.100 | 0.7822 | -0.7803 |
Free Cash Flow 1 | 0.1743 | 0.2042 | 0.1712 | -0.9805 | 0.2855 | -1.004 |
FCF margin | 2.61% | 2.81% | 2.42% | -10.47% | 2.94% | -10.19% |
FCF Conversion (EBITDA) | 143.27% | 58.86% | 33.6% | - | 27.08% | - |
FCF Conversion (Net income) | - | 121.69% | 62.58% | - | 45.62% | - |
Dividend per Share 2 | 0.1000 | - | 0.0700 | 0.2000 | - | - |
Announcement Date | 29/04/19 | 21/02/20 | 21/04/21 | 28/04/22 | 30/04/24 | 30/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 1.84 | 1.99 | 1.77 | 1.02 | 1.32 | 0.67 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 0.17 | 0.2 | 0.17 | -0.98 | 0.29 | -1 |
ROE (net income / shareholders' equity) | -1.42% | 3.07% | 4.97% | 14.8% | 9.52% | -9.6% |
ROA (Net income/ Total Assets) | -0.71% | 1.33% | 2.38% | 7.06% | 4.58% | -0.51% |
Assets 1 | 11.25 | 12.66 | 11.5 | 12.47 | 13.67 | 123.2 |
Book Value Per Share 2 | 6.770 | 6.880 | 6.900 | 7.930 | 8.510 | 7.750 |
Cash Flow per Share 2 | 2.310 | 2.480 | 2.210 | 1.270 | 1.650 | 0.8400 |
Capex 1 | 0.09 | 0.19 | 0.52 | 1.11 | 0.84 | 2.48 |
Capex / Sales | 1.3% | 2.62% | 7.27% | 11.85% | 8.7% | 25.17% |
Announcement Date | 29/04/19 | 21/02/20 | 21/04/21 | 28/04/22 | 30/04/24 | 30/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-16.51% | 76.78L | |
-23.39% | 1.56TCr | |
-2.70% | 1.17TCr | |
+2.65% | 1.16TCr | |
+2.85% | 1.01TCr | |
+29.48% | 869.89Cr | |
-10.66% | 715.53Cr | |
+8.05% | 684.58Cr | |
+1.43% | 619.62Cr | |
+9.92% | 429.78Cr |
- Stock Market
- Equities
- UOM Stock
- Financials AS Latvijas Juras medicinas centrs